Preterm infant care forms a significant part of the pediatric healthcare market in the U.S. as preterm births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are preterm, and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking. Preterm infant care products (equipment, drugs, and formulae) can thus be life-critical as they provide the respiratory, nutritional, and thermal support necessary for the survival of pre-term babies. The vital role of these products in preterm infant care thus forms the major factor driving market growth.
Market Estimates and Forecasts
In addition to market data on the submarkets of the U.S. preterm infant care market, each section of the report will identify and analyze the market trends, opportunities, and the factors driving or inhibiting market growth. The report will also draw a competitive landscape, in which it will profile the top 35 market players. The report categorizes the U.S. Preterm Infant Care market as follows :
• Preterm Infant Care Equipment (Diagnosis, therapy, and monitoring)
• Preterm Infant Formula (For use in hospitals, after discharge, iron fortified cow’s milk formulas, hydrolyzed whey based formulas, casein hydrolysate formulas, amino acid formulas)
• Preterm Infant Care Drugs (Antibiotics, bronchodilators, analgesics, diuretics, vassopressors, hematologic agents)
• Preterm Infant Care Services Market ((Diagnosis, therapy, and monitoring)
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT.
We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
Key questions answered
- Which are the high-growth segments/cash cows and how is the market segmented in terms of devices, infant formula, drugs, services?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
To know more about this report & to buy a copy please visit:
http://www.visionshopsters.com/product/2211/U-S-Preterm-Infant-Care-Market.html
Table Of Contents :
1 INTRODUCTION
1.1KEY TAKE AWAYS
1.2REPORT DESCRIPTION
1.3MARKET ESTIMATES AND FORECASTS
1.4STAKEHOLDERS
1.5RESEARCH METHODOLOGY
2 SUMMARY
3 MARKET OVERVIEW
3.1SOCIOECONOMIC IMPACT & COST ANALYSIS
3.2DRIVERS
3.2.1INCREASING INCIDENCE OF PRETERM BIRTHS
3.2.1.1Inappropriate maternal age
3.2.1.2Induced fertility treatments
3.2.1.3Genetic predisposition
3.2.1.4Lack of awareness and inadequate prenatal care
3.2.1.5Obesity, diabetes, smoking
3.2.2AVAILABILITY OF LOW-COST EQUIPMENT
3.2.3GOVERNMENT INITIATIVES
3.3RESTRAINTS & OPPORTUNITIES
3.3.1HIGH ENTRY BARRIERS
3.3.2NOVEL TRENDS IN INFANT FORMULAE
3.3.3TECHNOLOGY DEVELOPMENTS
3.4NOVEL APPROACHES TO PRETERM INFANT CARE
3.4.1DEVELOPMENTAL CARE
3.4.2NEONATAL INFORMATION SYSTEMS
3.5KEY FINDINGS
4 PRETERM INFANT CARE SERVICES MARKET
4.1OVERVIEW
4.2THERAPY & MONITORING SERVICES
4.3DIAGNOSIS
5 U.S. PRETERM INFANT CARE, PRODUCTS MARKET
5.1OVERVIEW
5.2DELIVERY SYSTEMS
5.2.1DRIVERS
5.2.1.1Integral part of preterm babies treatment
5.2.1.2Replacement units & price differentiation generating revenues
5.2.2RESTRAINTS
5.2.2.1Lack of technology differentiation
5.2.2.2Low priced devices
5.2.3OPPORTUNITY
5.2.3.1Systems addressing pain management
5.2.4FEEDING TUBES
5.2.5INTRAVENOUS LINES
5.2.6UMBILICAL CATHETER
5.2.7PERIPHERALLY INSERTED CENTRAL CATHETER LINE
5.3BILI LIGHTS
5.4RESPIRATORY ASSISTANCE DEVICES
5.4.1DRIVERS
5.4.1.1Life saving devices
5.4.1.2Large number of babies suffering from respiratory distress syndrome
5.4.1.3Changing technologies
5.4.2RESTRAINTS
5.4.2.1Life threatening harmful effects of some devices
5.4.2.2Low cost ventilators
5.4.2.3Opportunities
5.4.2.3.1Software solutions make the device user friendly
5.4.2.3.2Home care devices
5.5THERMAL CONTROL EQUIPMENTS
5.5.1DRIVERS
5.5.1.1Life saving portable and versatile equipment
5.5.1.2Portable and versatile systems
5.5.2RESTRAINT
5.5.2.1Low cost
5.5.3OPPORTUNITY
5.5.3.1Scope for structural improvements
5.6MONITORING DEVICES
5.6.1DRIVERS
5.6.1.1Novel IT solutions
5.6.1.2Non invasive techniques & point-of-care analyzers
5.6.1.2.1Increasing demand for reliable patient data
5.6.1.2.2Necessity of the devices in early detection of abnormality
5.6.2RESTRAINTS
5.6.2.1Cost reductions
5.6.3OPPORTUNITY
5.6.3.1Expanded use of microprocessing technology
5.6.3.2Lab-on-chip monitoring devices
5.6.3.3Nanobarcodes and RFID
5.7DIAGNOSTIC EQUIPMENT
5.7.1DRIVERS
5.7.1.1Technology advances enhancing consumption
5.7.2RESTRAINTS
5.7.2.1Requires high investments
5.7.2.2Inadequate clinical trials of the devices
5.7.3OPPORTUNITY
5.7.3.1Nano enabled devices & integration of nanotech and IT
5.7.4IMAGING EQUIPMENT
5.8PRE TERM INFANT FORMULA
5.9CHANGING TRENDS IN THE PRETERM INFANT FORMULA INDUSTRY
5.10PRETERM FORMULAS FOR USE IN HOSPITALS
5.11PRETERM FOLLOW-UP FORMULAS AFTER DISCHARGE
5.12DRUGS
6 COMPETITIVE LANDSCAPE
6.1OVERVIEW
7 GEOGRAPHIC ANALYSIS
7.1OVERVIEW
7.2OPPORTUNITIES
7.3MISSISSIPPI
7.3.1QUICK FACTS
7.3.2RISK FACTOR ANALYSIS
7.4ALABAMA
7.4.1QUICK FACTS
7.4.2RISK FACTOR ANALYSIS
7.5DISTRICT OF COLUMBIA
7.5.1QUICK FACTS
7.5.2RISK FACTOR ANALYSIS
7.6LOUISIANA
7.6.1QUICK FACTS
7.6.2RISK FACTOR ANALYSIS
7.7KENTUCKY
7.7.1QUICK FACTS
7.7.2RISK FACTOR ANALYSIS
7.8SOUTH CAROLINA
7.8.1RISK FACTOR ANALYSIS
7.9TENNESSEE
7.9.1RISK FACTOR ANALYSIS
7.10NEVADA
7.10.1RISK FACTOR ANALYSIS
7.11NEW MEXICO
7.11.1RISK FACTOR ANALYSIS
7.12GEORGIA
7.12.1RISK FACTOR ANALYSIS
7.13WEST VIRGINIA
7.13.1RISK FACTOR ANALYSIS
7.14OKLAHOMA
7.14.1RISK FACTOR ANALYSIS
7.15FLORIDA
7.15.1RISK FACTOR ANALYSIS
7.16TEXAS
7.16.1RISK FACTOR ANALYSIS
7.17ARKANSAS
7.17.1RISK FACTOR ANALYSIS
7.18CALIFORNIA
7.18.1RISK FACTOR ANALYSIS
7.19NEW YORK
7.19.1RISK FACTOR ANALYSIS
7.20OHIO
7.20.1RISK FACTOR ANALYSIS
7.21ILLINOIS
7.21.1RISK FACTOR ANALYSIS
7.22PENNSYLVANIA
7.22.1RISK FACTOR ANALYSIS
8 PATENT ANALYSIS
8.1PATENT ANALYSIS BY ASSIGNEE
8.2PATENT ANALYSIS BY PRODUCTS
8.3PATENT ANALYSIS BY EQUIPMENT
9 COMPANY PROFILES
9.1ABBOTT NUTRITION
9.2ANALOGIC CORP
9.3ATOM MEDICAL INTERNATIONAL CORP.
9.4ARJOHUNTLEIGH
9.5CAREFUSION INC
9.6CAS MEDICAL SYSTEMS INC
9.7CHILDREN’S HOSPITAL OF PHILADELPHIA
9.8CHILDREN’S NATIONAL MEDICAL CENTER
9.9CLINICAL INNOVATIONS
9.10COVIDIEN LTD.
9.11CRITICARE SYSTEMS, INC.
9.12DRAEGERWERK AG & CO. KGAA
9.13EDAN INSTRUMENTS, INC
9.14FISHER & PAYKEL HEALTHCARE CORP.
9.15FUKUDA DENSHI CO. LTD.
9.16GE HEALTHCARE
9.17HAMILTON MEDICAL AG
9.18KCBIOMEDIX, INC
9.19MASIMO CORP.
9.20MEAD JOHNSON NUTRITION CO
9.21MEDELA INC.
9.22MEDIX I.C.S.A
9.23NATUS MEDICAL INC.
9.24NESTLE NUTRITION
9.25NEWYORK-PRESBYTERIAN MORGAN STANLEY CHILDREN’S HOSPITAL
9.26NIHON KOHDEN CORP.
9.27NONIN MEDICAL INC.
9.28ORIDION SYSTEMS LTD
9.29PEDIATRIX MEDICAL GROUP
9.30PHOENIX MEDICAL SYSTEMS PVT LTD
9.31PHILIPS RESPIRONICS INC
9.32SPACELABS MEDICAL, INC
9.33UTAH MEDICAL PRODUCTS, INC.
9.34WELCH ALLYN INC.
9.35WYETH NUTRITION CORP
APPENDIX
PATENTS
LIST OF TABLES
SUMMARY TABLE U.S. PRETERM INFANT CARE MARKET 2007 – 2014 ($MILLIONS)
TABLE 1U.S. PRETERM INFANT CARE MARKET, BY SEGMENT 2007 – 2014 ($MILLIONS)
TABLE 2U.S. PRETERM INFANT CARE SERVICES MARKET, 2007 – 2014 ($MILLIONS)
TABLE 3U.S. PRETERM INFANT CARE EQUIPMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLIONS)
TABLE 4 U.S. PRETERM INFANT CARE THERAPY & MONITORING EQUIPMENT MARKET, 2007 – 2014 ($MILLIONS)
TABLE 5 PREMATURE DIAGNOSTIC DEVICES
TABLE 6 THERMAL CONTROL DEVICES
TABLE 7 MONITORING DEVICES
TABLE 8 DIAGNOSTIC EQUIPMENT
TABLE 9U.S. PRETERM INFANT FORMULA MARKET, BY PRODUCTS 2007 – 2014 ($MILLIONS)
TABLE 10AGREEMENTS AND COLLABORATIONS IN THE PRETERM INFANT CARE MARKET (2007-2009)
TABLE 11NEW PRODUCT LAUNCHES IN THE PRETERM INFANT CARE MARKET (2007-2009)
TABLE 12MERGERS AND ACQUISITIONS IN THE PRETERM INFANT CARE MARKET (2006-2009)
TABLE 13 PRETERM BIRTH RATE IN ETHNICITIES – MISSISSIPPI
TABLE 14 PRETERM BIRTH RATE IN ETHNICITIES – ALABAMA
TABLE 15 PRETERM BIRTH RATE IN ETHNICITIES – DISTRICT OF COLUMBIA
TABLE 16 PRETERM BIRTH RATE IN ETHNICITIES – LOUISIANA
TABLE 17 PRETERM BIRTH RATE IN ETHNICITIES – KENTUCKY
TABLE 18 PRETERM BIRTH RATE IN ETHNICITIES – SOUTH CAROLINA
TABLE 19 PRETERM BIRTH RATE IN ETHNICITIES – TENNESSEE
TABLE 20 PRETERM BIRTH RATE IN ETHNICITIES – NEVADA
TABLE 21 PRETERM BIRTH RATE IN ETHNICITIES – NEW MEXICO
TABLE 22 PRETERM BIRTH RATE IN ETHNICITIES – GEORGIA
TABLE 23 PRETERM BIRTH RATE IN ETHNICITIES – WEST VIRGINIA
TABLE 24 PRETERM BIRTH RATE IN ETHNICITIES – OKLAHOMA
TABLE 25 PRETERM BIRTH RATE IN ETHNICITIES – FLORIDA
TABLE 26 PRETERM BIRTH RATE IN ETHNICITIES – TEXAS
TABLE 27 PRETERM BIRTH RATE IN ETHNICITIES – ARKANSAS
TABLE 28 PRETERM BIRTH RATE IN ETHNICITIES – CALIFORNIA
TABLE 29 PRETERM BIRTH RATE IN ETHNICITIES – NEW YORK
TABLE 30 PRETERM BIRTH RATE IN ETHNICITIES – OHIO
TABLE 31 PRETERM BIRTH RATE IN ETHNICITIES – ILLINOIS
TABLE 32 PRETERM BIRTH RATE IN ETHNICITIES – PENNSYLVANIA
LIST OF FIGURES
FIGURE 1 CURRENT PRETERM BIRTH RATE IN THE U.S
FIGURE 2 SOCIOECONOMIC COSTS
FIGURE 3 INCREASING RATES PRETERM BIRTHS IN THE U.S.
FIGURE 4 PROMINENT RISK FACTORS CAUSING PRETERM BIRTHS
FIGURE 5 DEVELOPMENTAL CARE
FIGURE 6UTILIZATION RATES OF RESPIRATORY ASSISTANCE DEVICES IN PRETERM INFANT CARE
FIGURE 7TECHNOLOGY TRENDS IN THE RESPIRATORY ASSISTANCE DEVICES MARKET
FIGURE 8PERCENT UTILIZATION RATES OF THERMAL CONTROL EQUIPMENT
FIGURE 9TECHNOLOGY TRENDS IN THE MONITORING DEVICES MARKET
FIGURE 10TECHNOLOGY DEVELOPMENT IN THE DIAGNOSTIC EQUIPMENT MARKET
FIGURE 11UTILIZATION RATES OF DIAGNOSTIC EQUIPMENT IN PRETERM INFANT CARE
FIGURE 12PRODUCT DEVELOPMENT IN THEPRETERM INFANT CARE MARKET
FIGURE 13PRODUCT DEVELOPMENTS IN MEDICAL DEVICES
FIGURE 14NEW PRODUCT LAUNCHES
FIGURE 15AGREEMENTS AND COLLABORATIONS
FIGURE 16PRETERM BIRTH RATES, BY STATES
FIGURE 17PATENT ANALYSIS, BY ASSIGNEE (2000 – 2009)
FIGURE 18PATENTS ANALYSIS, BY PRODUCTS (2000 – 2009)
FIGURE 19PATENTS ANALYSIS, BY EQUIPMENT (2000 – 2009)
FIGURE 20PATENT ANALYSIS, BY THERAPY & MONITORING EQUIPMENT (2000 – 2009)
To know more about this report & to buy a copy please visit:
http://www.visionshopsters.com/product/2211/U-S-Preterm-Infant-Care-Market.html
Contact Us:
Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com